BeiGene, Ltd. (BGNE)
Last Price$226.70.0%
Market Cap$1,846.9M
Intrinsic value score
5/10
Good
Intrinsic value
$2,805.9
DCF value - N/A
Relative value - $2,805.9
Undervalued
1,137.7%
LTM P/E
(2.1x)
Peer set median (22.2x)
Discount rate
4.9%
BGNE Intrinsic value
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
BGNE Historical Intrinsic Value
Crunching data... Almost there!
BGNE vs Peer Set: Intrinsic Value Comparison
Crunching data... Almost there!
Explore more intrinsic value tools hub for BGNE
Peter Lynch Fair Value
Intrinsic Value
Earnings Power Value
Ben Graham Fair Value
Earnings growth model
DCF value calculator
Discount rate
Peter Lynch charts
Reverse DCF
Relative Value
FAQ
What is BeiGene, Ltd. intrinsic value?
As of Jan 29, 2025, BeiGene, Ltd. Intrinsic Value is $2,805.9. This suggests it may be undervalued by 1,137.7% compared to its current price of around $226.7.
What is BeiGene, Ltd. DCF (discounted cash flow) valuation?
As of Jan 29, 2025, BeiGene, Ltd.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $226.7, using a discount rate of 4.9% and terminal growth rate of 3.0%.
Is BeiGene, Ltd. overvalued or undervalued?
BeiGene, Ltd. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $2,805.9, compared to a market price of around $226.7. This suggests a potential undervaluation of 1,137.7%.